Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Although the vaccine Generex is developing is still in the pre-clinical trial stage, Ong is not concerned. “This is not a competition. We do not have enough vaccines for the world population. It is not that you can dominate the market if you are fast [in the commercialisation of vaccines],” he points out.
SUCH GREAT NEWS.
HWGB will have exclusive rights for the production, distribution and sale of the repurposed vaccine based on the polio vaccine for use in preventing Covid-19 infections in Southeast Asia Countries